ShiftPosts

Early Stage

Workforce management in real-time for healthcare industries

Analytics

Raised to Date:
$695,257 - RegCF
$2,415,257 - Total

Aggregate Commitments $

Platform

SeedInvest

Start Date

11/19/2020

Close Date

01/29/2021

Min. Goal

$25,000

Max. Goal

$1,070,000

Min. Investment

$1,000

Security Type

Convertible Note

Funding Type

RegCF / RegD 506(c)

Series

Pre-Seed

Valuation Cap

$4,000,000

Discount Rate

20%

Rolling Commitments $

Status
Funded
Reporting Date

01/31/2021

Days Remaining
Funded
% of Min. Goal

2,781%

% of Max. Goal

65%

Likelihood of Max
Funded
Avg. Daily Raise

$9,792

Momentum
Funded
Log in or create a free account today to gain access to KingsCrowd analytics.
Location

Stillwater, Minnesota

Industry

Healthcare & Pharmaceuticals

Tech Sector

EnterpriseTech

Distribution Model

B2B

Margin

High

Capital Intensity

Low

Business Type

Growth

ShiftPosts, with a $4 million valuation cap, is raising crowdfunding on SeedInvest. It is an end-to-end workforce management platform for the healthcare industry. The platform helps to manage schedules, gaps, and talent, all from one screen. Elizabeth Cooper and Dave McLean founded ShiftPosts in 2018. The current round of crowdfunding has a minimum target of $25,000 and a maximum target of $1,070,000, and the funds will be used towards software development, staff, and sales and marketing. ShiftPosts signed a contract with the largest Rx retailer in Canada in the first year of its operations. The company’s monthly revenue grew 60% from May to June 2020 and 80% from July to August 2020.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$37,464

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-680,297

$-186,404

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$37,482

$54,962

Accounts Receivable

$0

$0

Total Assets

$51,405

$55,013

Short-Term Debt

$143,636

$51,686

Long-Term Debt

$675,000

$181,598

Total Liabilities

$818,636

$233,284

Financials as of: 11/19/2020
Log in or create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Starter

$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual

Pro

$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Analyst Reports (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual

Merlin

$41.67 /month
billed annually
Full site access including KingsCrowd ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by KingsCrowd ratings
Company specific KingsCrowd rating and risk assessment
Get Merlin Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Analyst Report Analyst Report Methodology Article

Synopsis

It’s no secret that workforce management is a huge pain point for businesses. Companies rely on ever-expanding teams of administrators and managers to approve work hours, schedule shifts, and fill in for absences. It’s a complicated process that requires meeting the diverse needs of employees and managers alike — and human fallibility can lead to gaps in schedules, employee fraud, and lost productivity. 

Fortunately, the internet age offers better options for businesses than antiquated time cards and paper-based spreadsheets. These automated platforms can streamline workforce management and save costs overall. One industry that is increasingly turning towards these kinds of automated solutions is healthcare. While the American pharmaceutical industry in particular is a gigantic market — projected to reach a size of $685.45 billion by 2023 — it is fiercely competitive and subject to shifting market trends. In the wake of the coronavirus pandemic, healthcare companies are being pressured even more to shift to streamlined online solutions over clunky face-to-face systems. 

One of the most significant trends in the healthcare industry is a transition to gig work over long-term employment. While enabling employees to set their own hours and move from position to position is just what the doctor ordered for some healthcare professionals and a difficult new way of life for others, it is the reality of the current market. One of the largest challenges with this new way of doing business is managing the workforce — ensuring that there’s always someone to cover the next shift, someone qualified and eager to work.

ShiftPosts aims to address these challenges in the healthcare market. It employs an end-to-end workforce management platform that enables its customers — largely pharmaceuticals based in Canada — to schedule, fill gaps, and seek out talent in the gig economy. The software bypasses traditional staffing agencies, which take significant cuts of workers’ wages and result in poorer outcomes for pharmacies and pharmacists alike. Beginning with an entry into the Canadian pharmaceutical market, ShiftPosts plans to perfect its system before breaking into the more lucrative U.S. healthcare market.

ShiftPosts’ current SeedInvest raise has been rated a Neutral Deal by the KingsCrowd investment team.

Price

ShiftPosts’ pre-seed raise is valued at a $4 million cap with a 20% discount. Even for an early-stage company with an untested product, this valuation is quite low — making it an appealing opportunity for potential investors. The early stage of the company does elicit a word-of-caution. Given its pre-revenue state, it is difficult to predict just how successful its platform could turn out to be in the long term. However, due to its low valuation, ShiftPosts’ price score is quite high.

Market

While nowhere near the size of the American pharmaceutical market, Canada has a robust, government-financed healthcare system, and pharmaceutical sales overall have reached $27 billion as of 2017. As it prepares to break into the much larger American markets, ShiftPosts can certainly compensate for its startup costs by cutting into the Canadian market and presenting a cost-effective alternative to expensive and inefficient staffing agencies. 

Current trends — such as the ongoing digitization of services as a result of the COVID-19 pandemic and the “graying effect” that will increase demand for healthcare services in the coming decades — could end up expanding ShiftPosts’s addressable market and the market overall. However, an expanding market also means increased competition. It’s still unclear at this time just how much market dominance ShiftPosts could attain, especially if more mature companies try to expand into workforce management software. Thus, the company’s market score is rather low.

Team

While ShiftPosts has its strengths as a potential investment, the credentials of its team are somewhat lackluster compared to other evaluated startups. Elizabeth Cooper and Dave McLean serve as the company president and CEO, respectively. Cooper — who is an advisor for a number of other projects in education and environmental management — holds a B.A.Sc. in Biochemistry and Economics from the University of California. She specializes in working with young companies, of which ShiftPosts certainly is one. McLean holds a Ph.D. in Pharmacy Administration from the University of Minnesota. While he has served in leadership roles with United Resource Networks and other medical companies, he is not a big name in the industry.

ShiftPosts co-founders Bartek Jach and David Beynon are similarly unproven names. Jach is a recent graduate of the University of Toronto, earning a Masters in Business Administration. He worked six years as a project manager and interned with McKinsey prior to his involvement with ShiftPosts. Beynon has spent a decade in project management and analysis roles. 

A lack of industry experience and past entrepreneurial endeavors has made ShiftPosts’ team score its lowest across all five metrics.

Differentiators

ShiftPosts, at first glance, doesn’t seem to have much that makes it stand out from its competitors. It holds no patents, and its chosen market is competitive. However, the company has secured a number of strong partnerships with companies like McKesson Canada, PharmaChoice, and the British Columbia Pharmacy Association, representing thousands of stores. The company also has pilot programs in place with WalMart and CostCo, major U.S. pharmaceutical suppliers, and these relationships have the company well-positioned to expand its slowly-growing revenue. Workforce management in the gig economy is also a difficult challenge to address, and early results seem to indicate that ShiftPosts’ program is doing so ably. ShiftPosts’ middle of the road differentiators score is indicative of its early success balanced against the potential for a rival company to create a better solution.

Performance

While the company is at a pre-revenue stage, it has seen some early success in 2019, with $37,464 in net sales. The company has a long way to go before it can compensate for its up-front expenses — its net loss last year was $680,297. Still, it is significant for a company at this stage in its development to be taking in revenue at all. The company projects that it has sufficient runway for at least another year. 

ShiftPosts also has significant partnerships and pilot programs already in place, as mentioned in the previous section. This early traction paired with the beginning of sales has netted ShiftPosts an above average performance score.

Bearish Outlook

At this early stage of development, there are a lot of companies that don’t make it, and proven, experienced leadership can make a real difference in which companies succeed and which don’t. ShiftPosts is lacking somewhat in that area. Additionally, its business plan involves cutting out giants in the healthcare staffing industries — companies with significantly more technological and human resources to challenge ShiftPosts’s emergence into the market. ShiftPosts’ chosen field is also a turbulent one, subject to rapid technological innovation and product change. If the company fails to make a splash in its early days — or finds its eventual push into the U.S. market blocked by large competitors in the fierce U.S. healthcare market — it could find its early progress abruptly stalled. Investors should bear in mind the risk in trusting an untested team to deliver results.

Investors should also be aware of potential financial challenges facing the company. As of October 2020, the company had yet to file its 2019 tax return. In addition, the company holds several hundreds of thousands of dollars in debt. This is not unusual for a startup, but combined with the late tax filing, indicates a pressing need to perform well in this raise in order to ramp up marketing and development efforts.

Bullish Outlook

There’s no question that healthcare is an expanding industry, and that companies are hungry for digital workflow management. The COVID-19 pandemic has only accelerated this trend. By building on its established partnerships and improving its product’s user-friendliness and reliability, ShiftPosts could very well establish itself as a premier workflow management product for pharmaceuticals.

Executive Summary

ShiftPosts brings an end-to-end workforce management solution to the pharmaceutical industry. Its website enables pharmacies to schedule shifts, account for employee schedules, and fill gaps with pre-vetted members of the gig economy, all at a lower price point than dominant healthcare staffing agencies. ShiftPosts declares its product to be all-encompassing, including cultural and personality aspects of potential workers, which it believes are not addressed by competing solutions. 

The product is largely untested — but it has started to generate revenue, as the company’s strong partnerships with pharmaceuticals bear early fruit. ShiftPosts hopes to further develop its product offering in the Canadian pharmaceutical market before eventually expanding into the U.S. pharmaceutical and healthcare industries as a whole.

ShiftPosts faces an uphill battle with an untested team. Still, an expanding gig economy and a healthcare industry desperate to reduce costs may prove to be just the opening needed for this early-stage company to grow and thrive. For these reasons, the KingsCrowd investment team gave ShiftPosts a Neutral rating.

For questions regarding the KingsCrowd staff pick or ratings for this company, please reach out to support@kingscrowd.com.

Analysis written by Benjamin Potts.

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
ShiftPosts on SeedInvest
$
Platform: SeedInvest
Security Type: Convertible Note
Valuation: $4,000,000

Follow company

Follow ShiftPosts on SeedInvest
View on SeedInvest (Closed)
Bullish / Bearish
You're Bullish on ShiftPosts on SeedInvest

Thank you for your vote on ShiftPosts on SeedInvest

Bullish / Bearish
You're Bearish on ShiftPosts on SeedInvest

Thank you for your vote on ShiftPosts on SeedInvest